Market Research Report
Protein Binding Assays Market Size, Share & Trends Analysis Report By Technology (Equilibrium Dialysis), By Product & Services (Instruments), By End Use (Pharmaceutical & Biotechnology Companies), By Region, And Segment Forecasts, 2019 - 2026
|Published by||Grand View Research, Inc.||Product code||913841|
|Published||Content info||188 Pages
Delivery time: 2-3 business days
|Protein Binding Assays Market Size, Share & Trends Analysis Report By Technology (Equilibrium Dialysis), By Product & Services (Instruments), By End Use (Pharmaceutical & Biotechnology Companies), By Region, And Segment Forecasts, 2019 - 2026|
|Published: September 26, 2019||Content info: 188 Pages||
The global protein binding assays market size is expected to reach USD 683.09 million by 2026 at a CAGR of 10.6%, according to a new report by Grand View Research, Inc. Protein binding assays are increasingly being adopted in preclinical stages of drug discovery & development programs. These assays help in detection of target molecules and provide critical information about the properties of therapeutics and biologics.
Increase in number of R&D outsourcing activities by pharmaceutical companies for development of therapeutics is anticipated to increase the adoption of protein binding assays. Presence of several companies that provide these services for molecule investigation and analysis is expected to positively impact the market growth over the forecast period.
These assays provide help understand ADME properties during selection and development of therapeutic candidates. Estimation of safety margins during drug development is an important step that can be carried out by quantification of binding of new chemical entities to a protein.
Companies such as Thermo Fisher, Charles River, Sovicell, GE Healthcare, Evotec, and others have undertaken several strategic initiatives to enhance their market presence.